RapiDose

Medical Equipment Manufacturing • • 1-10 Employees

Company overview

Headquarters	XX
NAICS	3391
Employees	1-10

Key Contact at RapiDose

Anthony Phillips

Co-Founder

About RapiDose

In a paediatric emergency, every second counts—but calculating the right dose of adrenaline (epinephrine) can be complex and prone to error, especially in high-stress situations. RAPIDOSE is an innovative medical device designed to ensure accurate, weight-based adrenaline dosing for children in cardiac arrest. By eliminating the risk of overdose or underdose, RAPIDOSE enhances safety and improves outcomes when it matters most. This breakthrough technology is particularly vital for Out-of-Hospital Cardiac Arrest (OHCA), where resuscitation often needs to be conducted with minimal resources and personnel. Developed in collaboration with frontline healthcare providers, RAPIDOSE is easy to use, fast, and reliable—giving clinicians confidence in emergency care. With this device, we are taking a critical step toward preventing preventable harm and saving young lives. Stay tuned as RAPIDOSE moves closer to transforming paediatric emergency care!

RapiDose revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$547,552
Total funding	No funding